Celyad Oncology announces the publication of data from its Phase 1 THINK study of CYAD-01
MONT-SAINT-GUIBERT, Belgium, Feb. 09, 2023 (GLOBE NEWSWIRE) — Celyad Oncology (Euronext & Nasdaq: CYAD) (the…
Month: February 2023
Addex Regains Nasdaq Listing Compliance
Ad Hoc Announcement Pursuant to Art. 53 LR Geneva, Switzerland, February 9, 2023 – Addex…
Ipsen presents strong full-year 2022 results and guidance for 2023
2022 total sales up by 8.5% at CER1 (14.4% as reported) with growth platforms’2 sales…
Business shortlist revealed for global Sedex Sustainability Awards, celebrating improvement and innovation in supply chains
London, 9 February 2023 Leading sustainability data and technology company Sedex is delighted to announce…
Syneos Health Schedules Fourth Quarter and Full Year 2022 Earnings Call for Thursday, February 16th, 2023
MORRISVILLE, N.C., Feb. 08, 2023 (GLOBE NEWSWIRE) — Syneos Health® (Nasdaq:SYNH), the only fully integrated…
Stellate Ganglion Block Treatment in Bay Area Launched by Soft Reboot Wellness
Soft Reboot Wellness (+1 650-419-3330), a holistic therapy center in the Bay Area, has launched…
Celebrity Dentist Joins Montclair Dental Spa to Offer Frontier Porcelain Veneers
Catrise Austin best known for transforming celebrity smiles joins top cosmetic and spa dentistry practice…
AI Goes Dating: McAfee Study Shows 1 in 3 Men Plan to Use ChatGPT to Write Love Letters this Valentine’s Day
69% of adults were unable to tell the difference between a love letter written by…
Tivic Health Systems, Inc. Announces Pricing of Public Offering
SAN FRANCISCO–(BUSINESS WIRE)–$TIVC #healthcare—Tivic Health® Systems, Inc. (“Tivic”) (Nasdaq: TIVC), a commercial-phase health technology company…
EYLEA® (aflibercept) Injection Approved as the First Pharmacologic Treatment for Preterm Infants with Retinopathy of Prematurity (ROP) by the FDA
ROP is a leading cause of childhood blindness worldwide EYLEA now approved to treat five…
FDA Grants Regenerative Medicine Advanced Therapy (Rmat) Designation for Rexlemestrocel-L in Chronic Low Back Pain
NEW YORK, Feb. 08, 2023 (GLOBE NEWSWIRE) — Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in…
WonderFi Technologies Inc. Provides Corporate Update
Vancouver, British Columbia–(Newsfile Corp. – February 8, 2023) – WonderFi Technologies Inc. (TSX: WNDR) (OTCQB:…
CommScope’s Propel Honored by 2023 Lightwave Innovation Reviews
HICKORY, N.C.–(BUSINESS WIRE)–CommScope (NASDAQ: COMM), a global leader in network connectivity solutions, is pleased to…
Avantus Celebrates Galloway 2 Solar Project Groundbreaking in Texas
Concho County community members joined Avantus to celebrate the more than 250 workers responsible for…
MediciNova Announces Health Canada Grants Authorization to Commence Multi-arm Phase 2/3 Clinical Trial to Evaluate MN-166 (ibudilast) in Long COVID
LA JOLLA, Calif., Feb. 08, 2023 (GLOBE NEWSWIRE) — MediciNova, Inc., a biopharmaceutical company traded…
Lucy Scientific Discovery Inc. NASDAQ:LSDI Announces Pricing of $7.5 Million IPO
VICTORIA, British Columbia, Feb. 08, 2023 (GLOBE NEWSWIRE) — Lucy Scientific Discovery Inc. ( “the…
Cara Therapeutics Announces Results from the KOMFORT Phase 2 Trial of Oral Difelikefalin for the Treatment of Pruritus in Notalgia Paresthetica Published in the New England Journal of Medicine
Publication underscores the importance of data in underrecognized neuropathic itch disorder which lacks an approved…
Fulcrum Therapeutics to Participate at the Upcoming SVB Securities Global Biopharma Conference
CAMBRIDGE, Mass., Feb. 08, 2023 (GLOBE NEWSWIRE) — Fulcrum Therapeutics, Inc.® (Nasdaq: FULC), a clinical-stage…
Medexus Announces Another Record Quarter with Fiscal Q3 2023 Revenue of US$28.7 Million, a 35% Increase Over Fiscal Q3 2022
Results reflect growth across all leading prescription products, demonstrating continued track record of strong overall…
Flexera One Availability Expands in ANZ and APAC
Enterprises can maximise technology investments, aided by APAC shard that meets data residency requirements ITASCA,…